OneRobotics (Shenzhen) Co Ltd 06600.HK 上一季度的收入表現如何?
OneRobotics (Shenzhen) Co Ltd 的收入預期是多少?
OneRobotics (Shenzhen) Co Ltd 的盈利品質評分是多少?
OneRobotics (Shenzhen) Co Ltd 何時發布財報?
OneRobotics (Shenzhen) Co Ltd 的預期收益是多少?
OneRobotics (Shenzhen) Co Ltd 是否超出收益預期?
關鍵數據
前收市價
--
開盤價
--
當日範圍
-
52週區間
-
交易量
--
平均成交量
--
每股盈餘 (TTM)
--
股息收益率
--
市值
--
什麼是 OneRobotics (Shenzhen) Co Ltd?
SciClone Pharmaceuticals (Holdings) Ltd. is an investment holding company which manufactures and markets immune and oncology pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 1,050 full-time employees. The firm and its subsidiaries are principally engaged in developing and commercializing a portfolio of marketed products as well as pipelines with potential in their focused therapeutic areas including oncology and severe infection. The Company’s main products comprise Zadaxin, Zometa, Oravig, Angiomax, Endoxan, Holoxan, Cytosafe, Farlutal, Campto and Vizimpro. The Company’s pipeline products include ORSERDU, Vaborem, Vibativ, RRx-001 and Omburtamab. The Company’s products are mainly used in fields such as tumors, urinary tract infections, and skin and soft tissue infections. The firm mainly conducts its businesses in the domestic market.